Article

Cortisol suppression by dexamethasone reduces exaggerated fear responses in posttraumatic stress disorder

Emory University School of Medicine, Department of Psychiatry and Behavioral Sciences, Atlanta, GA 30303, United States.
Psychoneuroendocrinology (Impact Factor: 4.94). 05/2011; 36(10):1540-52. DOI: 10.1016/j.psyneuen.2011.04.008
Source: PubMed

ABSTRACT

PTSD symptoms are associated with heightened fear responses in laboratory fear conditioning paradigms. This study examined the effects of dexamethasone administration on hypothalamic-pituitary-adrenal (HPA) function and fear-potentiated startle (FPS) in trauma-exposed individuals with and without PTSD. We used an established fear discrimination procedure, in which one visual stimulus (CS+, danger cue) was paired with aversive airblasts to the throat (unconditioned stimulus, US), and another stimulus (CS-, safety cue) was presented without airblasts. In addition to FPS, the dexamethasone suppression test (DST) was performed. The study sample (N=100) was recruited from a highly traumatized civilian population in Atlanta, GA. Half of the subjects (n=54, 16 PTSD, 38 controls) underwent conditioning at baseline and the other half (n=46, 17 PTSD, 29 controls) after DST, in a cross-sectional design. We found a significant interaction effect of diagnostic group and dexamethasone treatment. Under baseline conditions, subjects with PTSD showed more than twice as much fear-potentiated startle to the danger cue compared to traumatized controls, F(1,53)=8.08, p=0.006. However, there was no group difference in subjects tested after dexamethasone suppression. Furthermore, there was a significant treatment effect in PTSD subjects but not in controls, with dexamethasone reducing fear-potentiated startle to the CS+, F(1,32)=4.00, p=0.05. There was also a positive correlation between PTSD subjects' FPS and cortisol levels, r=0.46, p=0.01. These results suggest that transient suppression of HPA function via dexamethasone suppression may reduce exaggerated fear in patients with PTSD.

Download full-text

Full-text

Available from: Kerry Ressler, Sep 16, 2014
  • Source
    • "Inconsistency in measurement of cortisol (e.g., diurnal vs. baseline vs. reactivity, plasma vs. saliva, etc.) may account for variability in sex-related findings (Olff, Langeland, Draijer, & Gersons, 2007). Cortisol itself may have an effect on fear learning, with different patterns for males and females (Jovanovic et al., 2011; Van Ast, Vervliet, & Kindt, 2012). Thus, it would seem that both biological propensities and social constructions maintain this gender disparity. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Posttraumatic stress (PTSS) and generalized anxiety symptoms (GAS) may ensue following trauma. While they are now thought to represent different psychopathological entities, it is not clear whether both GAS and PTSS show a dose-response to trauma exposure. The current study aimed to address this gap in knowledge and to investigate the moderating role of subjects' demographics in the exposure-outcome associations. The sample included 249 civilian adults, assessed during the 2014 Israel-Gaza military conflict. The survey probed demographic information, trauma exposure, and symptoms. PTSS but not GAS was associated with exposure severity. Women were at higher risk for both PTSS and GAS than men. In addition, several demographic variables were only associated with PTSS levels. PTSS dose-response effect was moderated by education. These findings are in line with emerging neurobiological and cognitive research, suggesting that although PTSS and GAS have shared risk factors they represent two different psychopathological entities. Clinical and theoretical implications are discussed.
    Full-text · Article · Aug 2015
  • Source
    • "In addition to its role in emotional behaviors, the BNST also regulates hypothalamic–pituitary–adrenal (HPA) activity (Cullinan et al. 1993; Gray et al. 1993; Herman et al. 1994; Herman and Cullinan 1997; Sullivan et al. 2004; Choi et al. 2007, 2008a,b; Green et al. 2007). Because intra-BNST CGRP infusions increase fos immunoreactivity in the paraventricular nucleus of the hypothalamus (Sink et al. 2011)—a nodal point in the HPA axis—and because HPA activity can influence fear learning and expression (Roozendaal 2002; Aerni et al. 2004; Donley et al. 2005; Schelling et al. 2006; Soravia et al. 2006; Tronel and Alberini 2007; Taubenfeld et al. 2009; Jovanovic et al. 2011; Zohar et al. 2011; Atsak et al. 2012; de Oliveira et al. 2013), we also examined the contribution of BNST CGRP receptors to shockinduced corticosterone release. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Calcitonin gene-related peptide (CGRP) infusions into the bed nucleus of the stria terminalis (BNST) evoke increases in startle amplitude and increases in anxiety-like behavior in the plus maze. Conversely, intra-BNST infusions of the CGRP antagonist CGRP8-37 block unconditioned startle increases produced by fox odor. Here we evaluate the contribution of CGRP signaling in the BNST to the development and expression of learned fear. Rats received five pairings of a 3.7-sec light and footshock and were tested for fear-potentiated startle one or more days later. Neither pre-training (Experiment 1) nor pre-test (Experiment 2) infusions of the CGRP antagonist CGRP8-37 (800 ng/BNST) disrupted fear-potentiated startle to the 3.7-sec visual cue. However, in both experiments, CGRP8-37 infusions disrupted baseline startle increases that occurred when rats were tested in the same context as that in which they previously received footshock (Experiment 3). Intra-BNST CGRP8-37 infusions did not disrupt shock-evoked corticosterone release (Experiment 4). These data confirm previous findings implicating BNST CGRP receptors in fear and anxiety. They extend those results by showing an important contribution to learned fear and, specifically, to fear evoked by a shock-associated context rather than a discrete cue. This pattern is consistent with previous models of BNST function that have posited a preferential role in sustained anxiety as opposed to phasic fear responses. More generally, the results add to a growing body of evidence indicating behaviorally, possibly clinically, relevant modulation of BNST function by neuroactive peptides.
    Preview · Article · Nov 2013 · Learning & memory (Cold Spring Harbor, N.Y.)
  • Source
    • "Besides the already mentioned causal link to SAM hyperdrive, a larger startle response was found to be positively associated with cortisol levels and negatively associated with the steroid hormone dehydroepiandrosterone (DHEA-S) [81]. Interestingly, cortisol suppression by dexamethasone reduces exaggerated startle responses in PTSD patients [82]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: PTSD can develop in the aftermath of traumatic incidents like combat, sexual abuse, or life threatening accidents. Unfortunately, there are still no biomarkers for this debilitating anxiety disorder in clinical use. Anyhow, there are numerous studies describing potential PTSD biomarkers, some of which might progress to the point of practical use in the future. Here, we outline and comment on some of the most prominent findings on potential imaging, psychological, endocrine, and molecular PTSD biomarkers and classify them into risk, disease, and therapy markers. Since for most of these potential PTSD markers a causal role in PTSD has been demonstrated or at least postulated, this review also gives an overview on the current state of research on PTSD pathobiology.
    Full-text · Article · Jul 2013 · Disease markers
Show more